Efficiency of Fornas Drug Procurement via E-Catalogue: Comparative Analysis of Price and Stock Availability Before and After Mandate
DOI:
https://doi.org/10.69855/jhsah.v1i1.360Keywords:
Efficiency, Stock Availability, Indonesia Fornas, E-Catalogue, Drug Procurement, PriceAbstract
This study evaluates the efficiency of National Formulary (Fornas) drug procurement via Indonesia’s mandatory E-Catalogue system by comparing drug prices and stock availability before and after its adoption. Using a retrospective quantitative design and Dual-Weighted Analysis (incorporating linear regression), this study analyzed 60 essential Fornas drugs using official LKPP pricing data and aggregated healthcare stock reports. Results conclusively show a significant 18.13% price reduction and price standardization post-implementation (p < 0.001), demonstrating strong financial efficiency. However, logistical efficiency remains unproven; aggregate stock availability increased only marginally by 2.7% (p=0.053), with a notable decline observed for high-cost vital drugs (Stratum A). The Simple Linear Regression analysis further reveals no statistically significant correlation between the realized price reduction and improvements in stock reliability (R = -0.15, p = 0.254). Findings highlight that while the E-Catalogue effectively serves as a cost brake, it does not yet ensure reliable supply for critical medicines, pointing to a fundamental dissociation between financial and logistical efficiency. Policy recommendations include revising pricing mechanisms for vital drugs, enhancing logistical monitoring, and strengthening demand planning capabilities. This research provides critical insights for policymakers and contributes to the evaluation of public pharmaceutical procurement policy beyond sole cost metrics.
References
Aisyah, S. (2017). The impact of the implementation of the National Health Insurance on drug prices at Jakarta Islamic Hospital Cempaka Putih. Journal of Health Policy Studies, 2(1), 1–7.
Dewi, A., & Santoso, Y. (2024). Beyond cost: Integrating logistics performance indicators into public e-procurement evaluation. International Journal of Public Sector Management, 15(3), 201–215.
Hamzah, K., & Ismail, I. (2021). Implementation of goods/services procurement policy through the e-purchasing system at the Regional Secretariat of Soppeng Regency. Ada Na Gau: Journal of Public Administration, 2(1), 429–438.
Harahap, D., & Sitorus, B. (2024). Health policy analysis using a quasi-experimental design: A case study of e-catalog implementation. Journal of Research Methodology, 14(1), 50–65.
Hutasoit, M. (2020). Analysis of e-catalog drug prices before and after the National Health Insurance era and the influencing factors at PT Kimia Farma Tbk [Undergraduate thesis, Universitas Gadjah Mada]. Universitas Gadjah Mada Repository. http://etd.repository.ugm.ac.id/penelitian/detail/188668
Kusuma, N. H., Indriani, T., & Purwoko, R. Y. (2023). Analysis of the effectiveness of the e-catalog system on the procurement of essential drugs at Hospital X. Journal of Health Service Management, 26(1), 10–18.
Madao, R., Makaba, S., & Bouway, D. (2023). Evaluation of e-catalogue drug procurement with e-purchasing and non-e-purchasing methods at Dekai Regional Hospital, Yahukimo Regency, Highland Papua Province, 2022. International Journal of Research and Review. https://doi.org/10.52403/ijrr.20230785
Prasetyo, Y. E., & Wulandari, S. (2024). The effect of e-purchasing implementation on procurement efficiency in terms of time and cost: A comparative study in the JKN era. Indonesian Journal of Pharmaceutical Sciences, 12(1), 1–10.
Puspita, R., & Haryanto, T. (2024). Measuring pharmaceutical supply chain resilience: A holistic model for JKN policy. Asian Journal of Health Economics and Policy, 18(1), 45–60.
Rohdiana, N., Saptaningsih, A., & Jus’at, I. (2024). Analysis of the differences in drug procurement via e-catalog in 2022 and 2023 at the pharmacy department of X hospital. Journal of Educational Innovation and Public Health. https://doi.org/10.55606/innovation.v2i3.3084
Saputra, A. R., & Setiawan, B. (2024). Comparison of national formulary drug availability levels: A study before and after the e-catalog mandate. Indonesian Journal of Health Administration, 12(2), 154–165.
Satibi, S., P., L., P., M., Hutasoit, M., & Pribadi, P. (2022). Analysis of e-catalogue drug prices in the era of universal health coverage in the Indonesian pharmaceutical industry. Pharmacia, 69, e83068. https://doi.org/10.3897/pharmacia.69.e83068
Siregar, C. N. (2022). Pharmaceutical management and national drug policy (4th ed.). EGC.
Wasir, R., Irawati, S., Makady, A., Postma, M., Goettsch, W., Buskens, E., & Feenstra, T. (2018). Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia. PLoS ONE, 14(2), e0212328. https://doi.org/10.1371/journal.pone.0212328
Wijaya, T. (2023). E-procurement and public procurement governance. Andi Publisher.
Winda, S. (2018). National formulary (FORNAS) and drug e-catalogue as a corruption prevention effort in national health insurance (JKN) drug governance. Integritas Journal, 4(2), 1–10. https://doi.org/10.32697/integritas.v4i2.328
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Health Service Administration and Hospital Management (LACERI)
This work is licensed under a Creative Commons Attribution 4.0 International License.
